Skip to main content

Critical Care Reviews Newsletter

Newsletter 522  |  December 13th 2021

Register for the free weekly newsletter

Dr Brian Driver Presents the Primary Outcome of the BOUGIE Trial

Dr Brian Driver Presents the Primary Outcome of the BOUGIE Trial

Welcome to the 522nd Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days.

The highlight of this week's edition is the presentation and publication of the BOUGIE trial, comparing emergency intubation with a bougie or a stylet in 1102 critically ill patients in the ED and ICU. This trial result was presented last week at a Critical Care Reviews Trials Result Livestream and simultaneously published in JAMA. 

The other notable papers include a randomised controlled trial comparing high-flow oxygen with conventional oxygen therapy in patients with severe COVID-19; systematic reviews and meta analyses comparing videolaryngoscopy with direct Macintosh laryngoscopy & convalescent plasma in COVID-19; and observational studies on phenotypes in paediatric patients with acute respiratory distress syndrome & noninvasive oxygenation strategy in COVID-19. There are also guidelines on coronary artery revascularization & antibiotic selection for severe nosocomial infections; narrative reviews on refractory intracranial hypertension, echocardiography in acute heart failure, & hemostasis testing in liver dysfunction; an editorial on why oesophageal intubations still go unrecognised; and a commentary on the omicron SARS-CoV-2 variant.

If you only have time to read one review article this week, try this one on COVID-19 and thrombosis.

Research

Randomised Controlled Trials

Systematic Review & Meta Analyses

Observational Studies

Reviews

Clinical

COVID-19
Neurological
Circulatory
Respiratory
Nutrition
Hepatobiliary
Renal
Paediatrics
Miscellaneous

Hematology ASH Education Program 2021

Neurology India series on Hydrocephalus

I hope you find this newsletter useful.


Until next week

Rob

 

Supported by

My Intensive Care Logo